Exploring the Existing Drug Space for Novel pTyr Mimetic and SHP2 Inhibitors
详细信息 查看全文
- 作者：Rongjun He ; Zhi-Hong Yu ; Ruo-Yu Zhang ; Li Wu ; Andrea M. Gunawan ; Brandon S. Lane ; Joong S. Shim ; Li-Fan Zeng ; Yantao He ; Lan Chen ; Clark D. Wells ; Jun O. Liu ; Zhong-Yin Zhang
- 刊名：ACS Medicinal Chemistry Letters
- 出版年：2015
- 出版时间：July 9, 2015
- 年：2015
- 卷：6
- 期：7
- 页码：782-786
- 全文大小：367K
- ISSN：1948-5875
文摘
Protein tyrosine phosphatases (PTPs) are potential therapeutic targets for many diseases. Unfortunately, despite considerable drug discovery efforts devoted to PTPs, obtaining selective and cell permeable PTP inhibitors remains highly challenging. We describe a strategy to explore the existing drug space for previously unknown PTP inhibitory activities. This led to the discovery of cefsulodin as an inhibitor of SHP2, an oncogenic phosphatase in the PTP family. Crystal structure analysis of SHP2 interaction with cefsulodin identified sulfophenyl acetic amide (SPAA) as a novel phosphotyrosine (pTyr) mimetic. A structure-guided and SPAA fragment-based focused library approach produced several potent and selective SHP2 inhibitors. Notably, these inhibitors blocked SHP2-mediated signaling events and proliferation in several cancer cell lines. Thus, SPAA may serve as a new platform for developing chemical probes for other PTPs.